<< Read Full Article
<< Read Full Article
AstraZeneca Lifts Profit Target
AstraZeneca (AZN Quote) delivered a third-quarter financial report Thursday that beat Wall Street's estimates and prompted the drugmaker to raise its earnings per share estimate.
The Anglo-British company lifted its full-year earnings target to a range of $2.85 to $2.90 a share from $2.75, marking the second upward revision in 2005. The average estimate among analysts polled by Thomson First Call was $2.79 for the year.
AstraZeneca produced an operating profit of $1.7 billion, or 76 cents a share, on sales of $5.79 billion. The third-quarter consensus was for EPS of 67 cents with sales of $5.75 billion. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,309.92 | 1,091.49 | 2,138.44 | 32.31 |
Oil *
77.12
|
|
DOWN
154.48
|
DOWN
19.14
|
DOWN
37.61
|
DOWN
0.48
|
10 Yr
3.23%
SPDR Gold
115.06
|
|
-1.48%
|
-1.72%
|
-1.73%
|
-1.46%
|
Data delayed 20 minutes |


Connect with TheStreet